F

Fennec Pharmaceuticals
D

FENC

10.320
USD
-0.07
(-0.67%)
مغلق
حجم التداول
3,234
الربح لكل سهم
0
العائد الربحي
-
P/E
-36
حجم السوق
358,486,150
أصول ذات صلة
المزيد
المقالات
المزيد

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.